You are adding an alert for:
Immuno-phenotyping of X-linked retinoschisis (XLRS) subjects in a Phase I/IIa AAV8-RS1 gene therapy clinical trial reveals baseline differences in systemic immune cell proportions but minimal further changes after vector administration.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: